IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eversept Partners, LP

Q3 2024 Holdings

Filed 2024-11-14 | 67 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Repligen Corp(RGEN)COM759916109$24.3M163,5931.7%
Healthequity Inc(HQY)COM42226A107$26.1M319,0781.8%
Zimvie Inc(ZIMV)COM98888T107$32.9M2,070,7802.3%
Spdr S&P 500 ETF TR(SPY)PutTR UNIT78462F103$34.4M60,0002.4%
United Therapeutics Corp del(UTHR)COM91307C102$46.9M130,9493.2%
HCA Healthcare Inc(HCA)COM40412C101$52.5M129,0843.6%
Bio-Techne Corp(TECH)COM09073M104$53.0M663,5733.6%
Community Health SYS Inc New(CYH)COM203668108$53.3M8,776,4553.6%
Teva Pharmaceutical Inds LTD(TEVA)SPONSORED ADS881624209$58.3M3,234,6384.0%
Inspire MED SYS Inc(INSP)COM457730109$58.3M276,2704.0%
Revvity Inc(RVTY)COM714046109$60.0M469,6924.1%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$79.0M4,105,3135.4%
Insmed Inc(INSM)COM PAR $.01457669307$79.5M1,089,4045.4%
Vera Therapeutics Inc(VERA)CL A92337R101$90.6M2,050,1576.2%
Natera Inc(NTRA)COM632307104$110.5M870,1937.6%
Invesco QQQ TR(QQQ)PutUNIT SER 146090E103$121.8M249,6008.3%
GSK PLC(GSK)SPONSORED ADR37733W204$165.9M4,057,20611.4%
PreviousPage 2 of 2